Poliomyelitis immunity status at different intervals from vaccination
- PMID: 3025013
- DOI: 10.1007/BF00211532
Poliomyelitis immunity status at different intervals from vaccination
Abstract
Research on neutralizing antibodies against the 3 serotypes of poliovirus was carried out on 441 blood specimens drawn from children and young people living in Parma, a town of about 200,000 inhabitants, where the vaccination services were well organized. From June 1983 to June 1984 blood samples were taken from different groups of subjects at different stages of vaccination (before vaccination, and after 1, 2, 3, and 4 doses of trivalent balanced OPV). In addition, groups of children and young people vaccinated from 2 to more than 14 years earlier were bled. Ten per cent of unvaccinated babies (aged 1-3 months) were lacking in neutralizing antibodies for types 1 and 3 and five per cent for type 2; among children aged 4-5 months vaccinated by one dose of OPV a residual 5% of subjects without antibodies for type 1 was also found. All subjects who received two, three, or four doses, had antibodies against all serotypes of poliovirus. As for the number of administered doses, significant differences among GMTs of antibodies were recorded only for type 1, when the group given 3 doses, was compared with the group which received two and one dose, respectively. At different intervals from completion of vaccination (2-14 years), all groups we examined still had antibodies against all three serotypes. For poliovirus type 1 antibody, GMTs were not significantly different in the examined groups. For types 2 and 3 significant decreases were observed in the groups vaccinated from 2 to 5 years. The high levels of immunity observed earlier in Parma were not found throughout the entire territory.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before.Eur J Epidemiol. 1991 Nov;7(6):605-11. doi: 10.1007/BF00218669. Eur J Epidemiol. 1991. PMID: 1664344
-
Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme.Trop Med Int Health. 2001 Dec;6(12):1032-9. doi: 10.1046/j.1365-3156.2001.00812.x. Trop Med Int Health. 2001. PMID: 11737841
-
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.Lancet. 1993 Jun 19;341(8860):1545-50. doi: 10.1016/0140-6736(93)90693-b. Lancet. 1993. PMID: 8099637 Clinical Trial.
-
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.Lancet Infect Dis. 2012 Feb;12(2):128-35. doi: 10.1016/S1473-3099(11)70190-6. Epub 2011 Nov 7. Lancet Infect Dis. 2012. PMID: 22071249 Clinical Trial.
-
Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?Public Health Rev. 1993-1994;21(1-2):143-50. Public Health Rev. 1993. PMID: 8041881 Review.
Cited by
-
Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before.Eur J Epidemiol. 1991 Nov;7(6):605-11. doi: 10.1007/BF00218669. Eur J Epidemiol. 1991. PMID: 1664344
-
Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy.Front Immunol. 2022 Feb 24;13:839362. doi: 10.3389/fimmu.2022.839362. eCollection 2022. Front Immunol. 2022. PMID: 35280985 Free PMC article.
-
Antipoliomyelitis neutralizing antibodies in maternal and neonatal serum.Eur J Epidemiol. 1997 Jul;13(5):559-65. doi: 10.1023/a:1007345930234. Eur J Epidemiol. 1997. PMID: 9258569
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials